Sernova Corp. 2022 Investor Deck - Cell Pouch System

Sernova Corp. is a regenerative medicine clinical-stage company developing the Cell Pouch System, an implantable device containing immunoprotected therapeutic cells for chronic diseases. The lead product targets type 1 diabetes by delivering insulin-producing cells to reduce or eliminate insulin injection dependency. The platform aims to provide a functional cure rather than symptomatic treatment.